Model: TRANXENE TABLETS

Clorazepate Dipotassium Tablets

Special Features:

Protective storage feature: security storage; controlled substance classification: schedule iv;

Properties:

Active Medicament Medicinal Strength
15.000 milligrams clorazepate dipotassium active ingredient
Primary Container Type
Bottle
Primary Container Content Quantity
500.000 tablets
NSN
6505-01-262-2176
Part Number
TRANXENE TABLETS
Description
Clorazepate Dipotassium Tablets,
CAGE
60060

Part TRANXENE TABLETS NSN 6505-01-262-2176

INC
FIIG
Concept No.
App. Key
Cond. Code
Status
INC:
66760
FIIG:
A510N0
Concept No.:
App. Key:
Cond. Code:
1
Status:
A

Material Classification

Hazardous material, precious metals, criticality, enviroment, and electrostatic discharge indicators
HMIC
PMIC
ESD/EMI
ENAC
MMAC
CRITL
HMIC:
P
PMIC:
A
ESD:
ESD:
MMAC:
CRITL:
X

Pricing & Availability Check

Submit this form for stock availability and pricing.
Part Number:
Quantity:
Email Address:
Phone Number:
Your Name:
Company:



Privacy Policy    Terms & Conditions

How to Order  

Ordering from buyaircraftparts.com

If you would like to order this clorazepate dipotassium tablets (NSN 6505-01-262-2176) please submit the pricing and availability form above to receive an up to date quote by email. If you agree to the pricing and terms you can e-sign your order online!

We are pleased to have the opportunity to serve you.

Have a Question

Hours: 08:00-18:00 Eastern Standard Time
Phone: +1 470-231-0824
Email: Contact Form »
Schedule B and Export
  • Schedule B: 3004909130
  • SITC: 54293
  • End Use: Pharmaceutical preparations
  • NAICS: 325412
  • USDA: 1

Freight Class: Anticonvulsants, hypnotics and sedatives, primarily affecting central nervous system, put up in measured doses or in forms or packings for retail sal

Highest Rated Parts
Recently Purchased Parts
Hot Parts